A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particle

Hepatology

Volumn 42, Issue 6, 2005, Pages 1300-1309

  Brandenburg, Boerries ^a   Stockl, Lars ^a   Gutzeit, Cindy ^a   Roos, Martin ^a   Lupberger, Joachim ^a   Schwartlander, Ruth ^b   Gelderblom, Hans ^a   Sauer, Igor M ^b   Hofschneider, Peter Hans ^c   Hildt, Eberhard ^a,b  

^a ROBERT KOCH INSTITUTE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; GREEN FLUORESCENT PROTEIN; HEPATITIS B SURFACE ANTIGEN; VIRUS FUSION PROTEIN;

ARTICLE; CELL MEMBRANE PERMEABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA PACKAGING; ENDOCYTOSIS; GENE DELIVERY SYSTEM; GENE TRANSFER; GENE TRANSLOCATION; GENETIC TRANSDUCTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LIVER CELL; MARKER GENE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; TRANSMISSION ELECTRON MICROSCOPY; VIRUS NUCLEOCAPSID; VIRUS PARTICLE;

CELLS, CULTURED; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; NUCLEOCAPSID; PERMEABILITY; VIRION; VIRUS ASSEMBLY;

EID: 32944476475     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20950     Document Type: Article

References (47)

1. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, et al. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A 1994;91:664-668.
2. Derossi D, Joliot AH, Chassaing G, Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 1994;269:10444-10450.
3. Pooga M, Soomets U, Hallbrink M, Valkna A, Saar K, Rezaei K, et al. Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat Biotechnol 1998;16:857-861.
4. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, et al. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 2001;276:5836-5840.
5. Oess S, Hildt E. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens. Gene Ther 2000;7:750-758.
6. Langel U. Cell penetrating peptides: processes and applications. London, UK: CRC Press, 2002.
7. Bennett RP, Dalby B, Guy PM. Protein delivery using VP22. Nat Biotechnol 2002;20:20.
8. Gratton JP, Yu J, Griffith JW, Babbitt RW, Scotland RS, Mickey R, et al. Cell-permeable peptides improve cellular uptake and therapeutic gene delivery of replication-deficient viruses in cells and in vivo. Nat Med 2003;9:357-362.
9. Eguchi A, Akuta T, Okuyama H, Senda T, Yokoi H, Inokuchi H, et al. Protein transduction domain of HIV-1 Tat protein promotes efficient delivery of DNA into mammalian cells. J Biol Chem 2001;276:26204-26210.
10. Lindsay MA. Peptide-mediated cell delivery: application in protein target validation. Curr Opin Pharmacol 2002;2:587-594.
11. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR, et al. In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J Neurosci 2002;22:5423-5431.
12. Wadia JS, Dowdy SF. Modulation of cellular function by TAT mediated transduction of full length proteins. Curr Protein Pept Sci 2003;4:97-104.
13. Hillemann A, Brandenburg B, Schmidt U, Roos M, Smirnow I, Lemken M, et al. Protein transduction with bacterial cytosine deaminase fused to the TLM intercellular transport motif induces profound chemosensitivity to 5-fluorocytosine in human hepatoma cells. J Hepatol. 2005;43:442-450.
14. Wynne SA, Crowther RA, Leslie AG. The crystal structure of the human hepatitis B virus capsid. Mol Cell 1999;3:771-780.
15. Bottcher B, Tsuji N, Takahashi H, Dyson MR, Zhao S, Crowther RA, et al. Peptides that block hepatitis B virus assembly: analysis by cryomicroscopy, mutagenesis and transfection. EMBO J 1998;17:6839-6845.
16. Hui EK, Chen KL, Lo SJ. Hepatitis B virus maturation is affected by the incorporation of core proteins having a C-terminal substitution of arginine or lysine stretches. J Gen Virol 1999;80(Pt 10):2661-2671.
17. Yeh CT, Liaw YF, Ou JH. The arginine-rich domain of hepatitis B virus precore and core proteins contains a signal for nuclear transport. J Virol 1990;64:6141-6147.
18. Koschel M, Thomssen R, Bruss V. Extensive mutagenesis of the hepatitis B virus core gene and mapping of mutations that allow capsid formation. J Virol 1999;73:2153-2160.
19. Lachmann S, Meisel H, Muselmann C, Koletzki D, Gelderblom HR, Borisova G, et al. Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope. Intervirology 1999;42:51-56.
20. Pumpens P, Grens E. HBV core particles as a carrier for B cell/T cell epitopes. Intervirology 2001;44:98-114.
21. Kramvis A, Kew MC. Structure and function of the encapsidation signal of hepadnaviridae. J Viral Hepatol 1998;5:357-367.
22. Bartenschlager R, Junker-Niepmann M, Schaller H. The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol 1990;64:5324-5332.
23. Hildt E, Munz B, Saher G, Reifenberg K, Hofschneider PH. The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J 2002;21:525-535.
24. Hafner A, Brandenburg B, Hildt E. Reconstitution of gene expression from a regulatory-protein-deficient hepatitis B virus genome by cell-permeable HBx protein. EMBO Rep 2003;4:767-773.
25. Begemann M, Policar M. Pneumococcal vaccine failure in an HIV-infected patient with fatal pneumococcal sepsis and HCV-related cirrhosis. Mt Sinai J Med 2001;68:396-399.
26. Dorko K, Freeswick PD, Bartoli F, Cicalese L, Bardsley BA, Tzakis A, et al. A new technique for isolating and culturing human hepatocytes from whole or split livers not used for transplantation. Cell Transplant 1994;3:387-395.
27. Conway JF, Watts NR, Belnap DM, Cheng N, Stahl SJ, Wingfield PT, et al. Characterization of a conformational epitope on hepatitis B virus core antigen and quasiequivalent variations in antibody binding. J Virol 2003;77:6466-6473.
28. Stockl L, Berting A, Malkowski B, Foerste R, Hofschneider PH, Hildt E. Integrity of c-Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression. Oncogene 2003;22:2604-2610.
29. Chen RW, Piiparinen H, Seppanen M, Koskela P, Sarna S, Lappalainen M. Real-time PCR for detection and quantitation of hepatitis B virus DNA. J Med Virol 2001;65:250-256.
30. Pyra H, Boni J, Schupbach J. Ultrasensitive retrovirus detection by a reverse transcriptase assay based on product enhancement. Proc Natl Acad Sci U S A 1994;91:1544-1548.
31. Nassal M. The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly. J Virol. 1992;66:4107-4116.
32. Dautry-Varsat A, Ciechanover A, Lodish HF. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc Natl Acad Sci USA 1983;80:2258-2262.
33. Gallina A, Bonelli F, Zentilin L, Rindi G, Muttini M, Milanesi G. A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids. J Virol 1989;63:4645-4652.
34. Lott L, Beames B, Notvall L, Lanford RE. Interaction between hepatitis B virus core protein and reverse transcriptase. J Virol 2000;74:11479-11489.
35. Zlotnick A, Cheng N, Conway JF, Booy FP, Steven AC, Stahl SJ, et al. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochemistry 1996;35:7412-7421.
36. Bartenschlager R, Schaller H. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J 1992;11:3413-3420.
37. Ziermann R, Ganem D. Homologous and heterologous complementation of HBV and WHV capsid and polymerase functions in RNA encapsidation. Virology 1996;219:350-356.
38. Derossi D, Calvet S, Trembleau A, Brunissen A, Chassaing G, Prochiantz A. Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J Biol Chem 1996;271:18188-18193.
39. Gansbacher B. Report of a second serious adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position of the European Society of Gene Therapy (ESGT). J Gene Med 2003;5:261-262.
40. Jeong JK, Yoon GS, Ryu WS. Evidence that the 5′-end cap structure is essential for encapsidation of hepatitis B virus pregenomic RNA. J Virol 2000;74:5502-5508.
41. Untergasser A, Protzer U. Hepatitis B virus-based vectors allow the elimination of viral gene expression and the insertion of foreign promoters. Hum Gene Ther 2004;15:203-210.
42. Birnbaum F, Nassal M. Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein. J Virol 1990;64:3319-3330.
43. Seifer M, Hamatake R, Bifano M, Standring DN. Generation of replication-competent hepatitis B virus nucleocapsids in insect cells. J Virol 1998;72:2765-2776.
44. Rabe B, Vlachou A, Pante N, Helenius A, Kann M. Nuclear import of hepatitis B virus capsids and release of the viral genome. Proc Natl Acad Sci U S A 2003;100:9849-9854.
45. Crowther RA, Kiselev NA, Bottcher B, Berriman JA, Borisova GP, Ose V, et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 1994;77:943-950.
46. Deshayes S, Morris MC, Divita G, Heitz F. Cell-penetrating peptides: tools for intracellular delivery of therapeutics. Cell Mol Life Sci. 2005;62:1839-1849.
47. Cooper A, Shaul Y. Recombinant viral capsids as an efficient vehicle of oligonucleotide delivery into cells. Biochem Biophys Res Commun 2005;327:1094-1099.